Vanguard Group Inc 4 D Molecular Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,767,717 shares of FDMT stock, worth $21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,767,717

Previous 2,528,180 9.47%

Holding current value

$21 Million

Previous $53.1 Million 43.62%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$10.81 - $27.22 $2.59 Million - $6.52 Million	239,537 Added 9.47%	2,767,717 $29.9 Million
Q2 2024 Aug 13, 2024	BUY	$20.93 - $30.01 $3.94 Million - $5.65 Million	188,237 Added 8.04%	2,528,180 $53.1 Million
Q1 2024 May 10, 2024	BUY	$17.03 - $35.87 $8.06 Million - $17 Million	473,094 Added 25.34%	2,339,943 $74.6 Million
Q4 2023 Feb 14, 2024	SELL	$9.76 - $21.25 $347,631 - $756,882	-35,618 Reduced 1.87%	1,866,849 $37.8 Million
Q3 2023 Nov 14, 2023	SELL	$12.64 - $19.76 $892,826 - $1.4 Million	-70,635 Reduced 3.58%	1,902,467 $24.2 Million
Q2 2023 Aug 14, 2023	BUY	$15.16 - $23.26 $6.48 Million - $9.94 Million	427,218 Added 27.64%	1,973,102 $35.7 Million
Q1 2023 May 15, 2023	BUY	$15.45 - $23.19 $4.23 Million - $6.35 Million	273,674 Added 21.51%	1,545,884 $26.6 Million
Q4 2022 Feb 10, 2023	SELL	$6.85 - $25.46 $329,841 - $1.23 Million	-48,152 Reduced 3.65%	1,272,210 $28.3 Million
Q3 2022 Nov 14, 2022	SELL	$6.96 - $11.48 $12,437 - $20,514	-1,787 Reduced 0.14%	1,320,362 $10.6 Million
Q2 2022 Aug 12, 2022	BUY	$5.68 - $15.99 $177,261 - $499,015	31,208 Added 2.42%	1,322,149 $9.23 Million
Q1 2022 May 13, 2022	BUY	$13.16 - $22.64 $103,411 - $177,905	7,858 Added 0.61%	1,290,941 $19.5 Million
Q4 2021 Feb 14, 2022	BUY	$19.56 - $32.94 $6.59 Million - $11.1 Million	337,106 Added 35.64%	1,283,083 $28.2 Million
Q3 2021 Nov 12, 2021	BUY	$22.73 - $36.04 $10.8 Million - $17.1 Million	475,701 Added 101.15%	945,977 $25.5 Million
Q2 2021 Aug 13, 2021	BUY	$22.2 - $42.29 $10.4 Million - $19.9 Million	470,276 New	470,276 $11.3 Million

Others Institutions Holding FDMT

# of Institutions

144

Shares Held

57.7M

Call Options Held

137K

Put Options Held

111K

View Full List

About 4D Molecular Therapeutics, Inc.

Ticker FDMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,382,400
Market Cap $246M
Description
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...

More about FDMT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc 4 D Molecular Therapeutics, Inc. Transaction History